115 related articles for article (PubMed ID: 8086742)
1. [Front-loading rt PA thrombolytic therapy in central or venous branch occlusions of the retina].
Steinkamp GW; Hattenbach LO; Scharrer I; Ohrloff C
Ophthalmologe; 1994 Jun; 91(3):280-2. PubMed ID: 8086742
[TBL] [Abstract][Full Text] [Related]
2. Retinal vein occlusion and low-dose fibrinolytic therapy (R.O.L.F.): a prospective, randomized, controlled multicenter study of low-dose recombinant tissue plasminogen activator versus hemodilution in retinal vein occlusion.
Hattenbach LO; Friedrich Arndt C; Lerche R; Scharrer I; Baatz H; Margaron F; Richard G; Behrens-Baumann W; Ohrloff C
Retina; 2009; 29(7):932-40. PubMed ID: 19584651
[TBL] [Abstract][Full Text] [Related]
3. [Treatment trials of plasminogen activator (rt-PA) in central vein thrombosis of the retina].
Reim M; Bertram B; Wolf S
Klin Wochenschr; 1988; 66 Suppl 12():143-9. PubMed ID: 3126343
[TBL] [Abstract][Full Text] [Related]
4. [Selective percutaneous transluminal thrombolytic therapy with rt-PA in central retinal artery occlusion].
Vulpius K; Höh H; Lange H; Maercker W; Rühle H
Ophthalmologe; 1996 Apr; 93(2):149-53. PubMed ID: 8652980
[TBL] [Abstract][Full Text] [Related]
5. Intravenous thrombolysis with low-dose recombinant tissue plasminogen activator in central retinal artery occlusion.
Hattenbach LO; Kuhli-Hattenbach C; Scharrer I; Baatz H
Am J Ophthalmol; 2008 Nov; 146(5):700-6. PubMed ID: 18718570
[TBL] [Abstract][Full Text] [Related]
6. Retinal endovascular lysis in ischemic central retinal vein occlusion: one-year results of a pilot study.
Feltgen N; Junker B; Agostini H; Hansen LL
Ophthalmology; 2007 Apr; 114(4):716-23. PubMed ID: 17141322
[TBL] [Abstract][Full Text] [Related]
7. The role of vitrectomy assisted rt-PA injection for the management of branch retinal vein occlusion: case report.
Christodoulakis EV; Tsilimbaris MK
Semin Ophthalmol; 2007; 22(2):89-93. PubMed ID: 17564929
[TBL] [Abstract][Full Text] [Related]
8. Retinal vein cannulation with prolonged infusion of tissue plasminogen activator (t-PA) for the treatment of experimental retinal vein occlusion in dogs.
Tameesh MK; Lakhanpal RR; Fujii GY; Javaheri M; Shelley TH; D'Anna S; Barnes AC; Margalit E; Farah M; De Juan E; Humayun MS
Am J Ophthalmol; 2004 Nov; 138(5):829-39. PubMed ID: 15531319
[TBL] [Abstract][Full Text] [Related]
9. [Systemic lysis therapy in retinal vascular occlusions].
Hattenbach LO
Ophthalmologe; 1998 Aug; 95(8):568-75. PubMed ID: 9782735
[TBL] [Abstract][Full Text] [Related]
10. Intravitreal tissue plasminogen activator for acute central retinal vein occlusion.
Lahey JM; Fong DS; Kearney J
Ophthalmic Surg Lasers; 1999 Jun; 30(6):427-34. PubMed ID: 10392729
[TBL] [Abstract][Full Text] [Related]
11. Intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke: initial Israeli experience.
Schwammenthal Y; Drescher MJ; Merzeliak O; Tsabari R; Bruk B; Feibel M; Hoffman C; Bakon M; Rotstein Z; Chapman J; Tanne D
Isr Med Assoc J; 2004 Feb; 6(2):70-4. PubMed ID: 14986460
[TBL] [Abstract][Full Text] [Related]
12. [Thrombolytic therapy with recombinant tissue-type plasminogen activator in patients with branch or central vein occlusion of the retina].
Kreutzer A; Brunner R; Schäfer HJ; Sickel W; Auel H; Hossmann V
Fortschr Ophthalmol; 1988; 85(5):511-3. PubMed ID: 3147230
[No Abstract] [Full Text] [Related]
13. Intravitreal tissue plasminogen activator for the treatment of central retinal vein occlusion.
Weizer JS; Fekrat S
Ophthalmic Surg Lasers Imaging; 2003; 34(4):350-2. PubMed ID: 12875471
[TBL] [Abstract][Full Text] [Related]
14. Treatment of retinal arterial occlusion with local fibrinolysis using recombinant tissue plasminogen activator.
Richard G; Lerche RC; Knospe V; Zeumer H
Ophthalmology; 1999 Apr; 106(4):768-73. PubMed ID: 10201601
[TBL] [Abstract][Full Text] [Related]
15. Prevalent misconceptions about acute retinal vascular occlusive disorders.
Hayreh SS
Prog Retin Eye Res; 2005 Jul; 24(4):493-519. PubMed ID: 15845346
[TBL] [Abstract][Full Text] [Related]
16. [Surgical approach to retinal vein occlusion].
Mester U
Klin Monbl Augenheilkd; 2005 Apr; 222(4):299-308; quiz R19-R38. PubMed ID: 15844038
[TBL] [Abstract][Full Text] [Related]
17. Thrombolytic therapy for central retinal vein occlusion: results of a pilot study.
Elman MJ
Trans Am Ophthalmol Soc; 1996; 94():471-504. PubMed ID: 8981710
[TBL] [Abstract][Full Text] [Related]
18. Clopidogrel-rt-PA-heparin combination in the treatment of acute myocardial infarction.
Bassand JP; Cariou R; Grollier G; Kragten J; Wolf JE; Heyndrickx GR
Semin Thromb Hemost; 1999; 25 Suppl 2():69-75. PubMed ID: 10440428
[TBL] [Abstract][Full Text] [Related]
19. [Value of local ophthalmic artery fibrinolysis in severe forms of central retinal vein occlusion].
Vallée JN; Aymard A; Paques M; Santiago PY; Gaudric A; Merland JJ
J Radiol; 2001 Feb; 82(2):137-44. PubMed ID: 11428208
[TBL] [Abstract][Full Text] [Related]
20. Fibrinolytic therapy with low-dose recombinant tissue plasminogen activator in retinal vein occlusion.
Hattenbach LO; Steinkamp G; Scharrer I; Ohrloff C
Ophthalmologica; 1998; 212(6):394-8. PubMed ID: 9787229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
